某医院4 084例妇科门诊患者HPV感染特征分析

范凌晔; 詹平; 汪春燕; 刘尧芳

doi:10.16016/j.2097-0927.202206015

您当前的位置：

首页 >

文章列表页 >

某医院4 084例妇科门诊患者HPV感染特征分析

临床医学 | 更新时间：2026-01-09

- 某医院4 084例妇科门诊患者HPV感染特征分析
- Characteristics of HPV infection among 4 084 gynecological outpatients
- 陆军军医大学学报 2023年45卷第4期页码：335-342
- 作者机构：
  
  1.646000 四川泸州, 西南医科大学附属医院妇科，四川省妇科及乳腺疾病治疗中心
  2.646000 四川泸州, 西南医科大学附属医院生殖中心
- 作者简介：
  
  [ 刘尧芳，E-mail：yaofangliu@qq.com LIU Yaofang, E-mail: yaofangliu@qq.com
- 基金信息：
  
  泸州市科技计划项目(2021-SYF-32)
- DOI：10.16016/j.2097-0927.202206015
  中图分类号： R195.4;R373.9;R711.74
- 收稿：2022-06-06，
  
  修回：2022-07-01，
  
  纸质出版：2023-02-28
- 稿件说明：
移动端阅览
范凌晔, 詹平, 汪春燕, 等. 某医院4 084例妇科门诊患者HPV感染特征分析[J]. 陆军军医大学学报, 2023,45(4):335-342.

Lingye FAN, Ping ZHAN, Chunyan WANG, et al. Characteristics of HPV infection among 4 084 gynecological outpatients[J]. Journal of Army Medical University, 2023, 45(4): 335-342.
范凌晔, 詹平, 汪春燕, 等. 某医院4 084例妇科门诊患者HPV感染特征分析[J]. 陆军军医大学学报, 2023,45(4):335-342. DOI： 10.16016/j.2097-0927.202206015.

Lingye FAN, Ping ZHAN, Chunyan WANG, et al. Characteristics of HPV infection among 4 084 gynecological outpatients[J]. Journal of Army Medical University, 2023, 45(4): 335-342. DOI： 10.16016/j.2097-0927.202206015.

摘要

目的

调查不同年龄女性人乳头瘤病毒(human papillomavirus，HPV)感染亚型的分布及其与宫颈病变的关联。

方法

将2015年1月至2020年6月于我院就诊，行阴道镜病理检查和HPV分型检测的4 084例患者进行横断面研究。根据年龄分为5组，根据病理结果分为6组：宫颈炎、CIN Ⅰ、CIN Ⅱ、CIN Ⅲ、宫颈原位癌、宫颈癌(cervical cancer

CC)组。采用

检验比较组间差异，分析HPV感染的总体状况及不同年龄组中阳性检出率、亚型分布、单一和多重基因亚型感染的差异，比较不同年龄组的HPV多重基因亚型感染情况。采用Spearman相关性分析比较不同年龄组和不同宫颈病变组中的HPV感染和亚型分布特征和不同宫颈病变在各年龄组的分布情况。

结果

4 084例患者中，HPV阳性检出率为93.24%，且不同年龄组的阳性检出率存在差异(

=11.400，

=0.022)；单一基因亚型感染占比64.67%，单一和多重基因亚型感染在不同年龄组间的差异具有统计学意义(

=70.736，

0.001)；检出的23种HPV亚型中，检出率前5的亚型是HPV16(31.88%)、HPV52(25.20%)、HPV58 (14.57%)、HPV18 (11.12%)和HPV51(7.81%)；在不同宫颈病变组间，阳性检出率的差异具有统计学意义(

0.05)。宫颈癌中，感染最多的亚型是HPV16、HPV18、HPV52、HPV58和HPV33。Spearman相关性分析表明年龄和宫颈病变相关性显著(

=0.051，

=0.001)，各年龄组中CC检出率分别是0.29%(18~29岁)，1.08%(30~39岁)，3.52%(40~49岁)，4.09%(50~59岁)，10.37%(60~82岁)。

结论

HPV16、HPV52、HPV58和HPV18在妇科就诊女性中是易感染的基因亚型；宫颈癌的发生与HPV16和HPV18感染存在相关性，>40岁女性的宫颈癌风险显著偏高，且随年龄增加，就诊女性宫颈癌检出率也随之增大。

Abstract

Objective

To investigate the distribution of human papillomavirus (HPV) subtypes in women with different age and analyze the relationship between HPV and cervical lesions.

Methods

A cross-sectional study was conducted on 4 084 patients who underwent colposcopy for pathological examination and HPV genotyping assay in our hospital from January 2015 to June 2020. The patients are classified into 5 groups in respect to the age and 6 groups (the cervicitis

CIN Ⅰ

CIN Ⅱ

CIN Ⅲ

cervical carcinoma

in situ

and cervical cancer groups) in respect to pathological results respectively.

Chi

-square test was used to analyze the difference among groups mentioned and to analyze the overall situation of HPV infection

the positive rate of detection of HPV

subtype distribution

infection with single and multiple HPV genotypes among different age groups. Spearman's correlation analysis was used to analyze distribution characteristics of HPV subtypes infection and cervical lesion among different age groups.

Results

The positive rate of HPV was 93.24% (3808/4 084) different in 5 age groups(

Chi

-square=11.400

=0.022). The single subtype infection accounted for 64.67%

and the difference of single subtype infection and multiple subtypes infection was statistically significant among different age groups(

Chi

-square=70.736

0.001). HPV16(31.88%)、HPV52(25.20%)、HPV58 (14.57%)、HPV18 (11.12%)and HPV51(7.81%)were the top 5 among 23 subtypes of HPV detected. The distribution difference of positive rate of HPV was statistically significant among different lesion groups (

0.05). In the cervical cancer group

most patients were infected with HPV16

HPV 18

HPV 52

HPV 58

and HPV 33. Spearman's correlation analysis showed there was a significant co

rrelation between age and cervical lesions (

=0.051

=0.001). Positive rate of cervical cancer were 0.29% in age 18~29

1.08% in 30~39

3.52% in age 40~49

4.09% in age 50~59 and 10.37% in age 60~82.

Conclusion

HPV16

HPV 52

HPV 58 and HPV 18 are the most prevalent subtypes among 4 084 patients. HPV16 and HPV18 are relevant with cervical cancer. The risk of cervical cancer is significantly higher for women older than 40. The positive rate of cervical cancer increases with the age.

关键词

Keywords

references

FERLAY J, ERVIK M, LAM F, et al . Global cancer observatory: cancer today. [2022-03-01 ] . https://gco.iarc.fr/today https://gco.iarc.fr/today ..

World Health Organization. Human papillomavirus (HPV) and cervical cancer. [2020-5-18 ] . https://www.who.int/news-room/fact-sheets/detail/cervical-cancer https://www.who.int/news-room/fact-sheets/detail/cervical-cancer .

SMALL W Jr, BACON M A, BAJAJ A, et al . Cervical cancer: a global health crisis[J ] . Cancer, 2017, 123(13): 2404-2412. DOI: 10.1002/cncr.30667.

HARARI A, CHEN Z G, BURK R D. Human papillomavirus genomics: past, present and future[J]. Curr Probl Dermatol, 2014, 45: 1-18. DOI: 10.1159/000355952.

HU Z, MA D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications[J]. Cancer Med, 2018, 7(10): 5217-5236. DOI: 10.1002/cam4.1501.

BHATLA N, SINGHAL S. Primary HPV screening for cervical cancer[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 65: 98-108. DOI: 10.1016/j.bpobgyn.2020.02.008.

SAWAYAG F, SMITH-MCCUNE K, KUPPERMANN M. Cervical cancer screening: more choices in 2019[J]. JAMA, 2019, 321(20): 2018-2019. DOI: 10.1001/jama.2019.4595.

KARAD M, LEPE J S, PLANI A, et al . Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants[J ] . Croat Med J, 2021, 62(1): 68-79. DOI: 10.3325/cmj.2021.62.68.

GUTNIK H, KASTELIC P, OŠTRBENK VALEN A, et al . Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorph ologic features[J ] . Virchows Arch, 2020, 476(2): 251-260. DOI: 10.1007/s00428-019-02694-7.

HASHIM D, ENGESÆTER B, BAADSTRAND SKARE G, et al . Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening[J ] . Br J Cancer, 2020, 122(11): 1715-1723. DOI: 10.1038/s41416-020-0790-1.

魏葆珺, 李学祥, 齐军. 13 452例HPV亚型感染检测结果分析[J]. 标记免疫分析与临床, 2013, 20(3): 169-171. DOI: 10.11748/bjmy.issn.1006-1703.2013.03.015.

WEI B J, LI X X, QI J. Detection of human genotype Papilloma virus infection in 13 452 cases[J ] . Labeled Immunoass Clin Med, 2013, 20(3): 169-171. DOI: 10.11748/b jmy.issn.1006-1703.2013.03.015.

SCHIFFMAN M, SOLOMON D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologiccotesting[J]. N Engl J Med, 2013, 369(24): 2324-2331. DOI: 10.1056/NEJMcp1210379.

CURRY S J, KRIST A H, OWENS D K, et al . Screening for cervical cancer: us preventive services task force recommendation statement[J ] . JAMA, 2018, 320(7): 674-686. DOI: 10.1001/jama.2018.10897.

SASLOW D, SOLOMON D, LAWSON H W, et al . American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J ] . J Low Genit Tract Dis, 2012, 16(3): 175-204. DOI: 10.1097/LGT.0b013e31824ca9d5.

马惠萍, 焦翔, 赵艳花, 等. 山东省滕州地区人乳头瘤病毒筛查及基因型分析[J]. 中华临床感染病杂志, 2021(3): 203-207.

MA H P, JIAO X, ZHAO Y H, et al . Screening and genotype analysis of human Papilloma virus in Tengzhou area of Shandong Province[J ] . Chin J Clin Infect Dis, 2021(3): 203-207. DOI: 10.3760/cma.j.issn.1674-2397.2021.03.008..

HUH W K, AULT K A, CHELMOW D, et al . Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance[J ] . J Low Genit Tract Dis, 2015, 19(2): 91-96. DOI: 10.1097/LGT.0000000000000103.

LI M X, DU XX, LU M H, et al . Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China[J ] . J Med Virol, 2019, 91(3): 473-481. DOI: 10.1002/jmv.25331.

CHEN L, DONG Y, LI J, et al . The genomic distribution map of human papillomavirus in western China[J ] . Epidemiol Infect, 2021, 149: e135. DOI: 10.1017/S0950268821001175.

TAN S C, ISMAIL M P, DUSKI D R, et al . Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate[J ] . Biosci Rep, 2018, 38(2): BSR20171268. DOI: 10.1042/BSR20171268.

ZENG Z Y, YANG H T, LI Z B, et al . Prevalence and genotype distribution of HPVinfection in China: analysis of 51 345 HPV genotyping results from China's largest CAP certified laboratory[J ] . J Cancer, 2016, 7(9): 1037-1043. DOI: 10.7150/jca.14971.

周成, 柴艳梅, 陈蓉, 等. 湖北荆门地区2698例女性HPV感染情况及基因分型调查研究[J]. 陕西医学杂志, 2020, 49(11): 1523-1526. DOI: 10.3969/j.issn.1000-7377.2020.11.040.

ZHOU C, CHAI Y M, CHEN R, et al . Study on human papillomavirus infection and genotyping of 2 698 women in Jingmen[J ] . Shanxi Med J, 2020, 49(11): 1523-1526. DOI: 10.3969/j.issn.1000-7377.2020.11.040.

杜洪岩, 肖明明. 某地区6 590例妇科门诊患者宫颈人乳头瘤病毒感染情况及基因亚型分析[J]. 中国民康医学, 2020, 32(1): 127-128, 131. DOI: 10.3969/j.issn.1672-0369.2020.01.051.

DU H Y, XIAO M M. Analysis of cervical papillomavirus infection and its genotype in 6 590 gynecological outpatients in an area[J]. Med J Chin People Heal, 2020, 32(1): 127-128, 131. DOI: 10.3969/j.issn.1672-0369.2020.01.051.

ZHANG J Y, CHENG K Y, WANG Z L. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis[J]. Arch Gynecol Obstet, 2020, 302(6): 1329-1337. DOI: 10.1007/s00404-020-05787-w.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

全身炎症反应指数联合临床病理参数预测宫颈癌复发的模型建立与验证

3D打印模具在宫颈癌近距离治疗中重复使用可行性研究

RNA传感器IFIH1对HPV阳性的宫颈癌细胞增殖、迁移和侵袭的影响

宫颈癌微创根治术患者术后超早期活动的安全性研究

459例宫颈高级别鳞状上皮内病变患者HPV感染特点及高危HPV阴性的筛查特征分析